Ian Cook Email

Chief Medical Officer and SVP . NeuroSigma

Los Angeles, CA

Location

LinkedIn

Current Roles

Employees:
6
Revenue:
$0
About
NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology. NeuroSigma's Monarch eTNS® System is a bioelectronic medical device that uses external trigeminal nerve stimulation to treat neurological and neuropsychiatric disorders. In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD. The new Monarch Pediatric Care Co-Pay Program is making eTNS therapy available to a substantially greater number of children diagnosed with ADHD.
NeuroSigma Address
10960 Wilshire Boulevard
Los Angeles, CA
United States
NeuroSigma Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.